Background We aimed to explore whether the relationships of blood pressures (BPs) with
Alzheimer's disease (AD) endophenotypes varied by usage of antihypertensive drugs …

Epidemiological studies suggest an association between chronic blood pressure (BP)
changes and Alzheimer's disease (AD). In particular, there is growing evidence that …

Abstract Alzheimer's disease (AD), the most common cause of dementia and the fifth leading
cause of death in the adult population has a complex pathophysiological link with …

Background and Objectives Previous randomized controlled trials and longitudinal studies
have indicated that ongoing antihypertensive use in late life reduces all-cause dementia …

Alzheimer's disease (AD) is recognized as the leading cause of dementia, imposing a
significant economic toll on society. Despite the emergence of novel therapeutic approaches …

Midlife cerebrovascular risk factors increase risk of late life cognitive impairment and
dementia, while their presence in patients with dementia may lead to cognitive improvement …

Background: While mid-life hypertension represents a risk factor for the development of
Alzheimer's disease (AD), the risk after the age of 65 is less certain. Establishing …

Dementia is a common cause of disability and dependency among the elderly due to its
progressive neurodegenerative nature. As there is currently no curative therapy, it is of major …

Objectives: The aim of this study was to determine whether use of diuretics, angiotensin-1
receptor blockers (ARB), angiotensin-converting enzyme inhibitors (ACE-I), calcium channel …

Vascular risk factors are implicated in the pathogenesis of Alzheimer's disease (AD). There
is an age-dependent relationship between blood pressure and the risk of AD. Given the …